BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

PBPHvsJDOCETF Comparison

ETF 1

PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

This fund is part of

DM Large & Mid Cap

+0.21%

Full PBPH fund page

VS

ETF 2

JDOC

JPMorgan Healthcare Leaders ETF

This fund is part of

Global Blended Cap

+0.47%

Full JDOC fund page

Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) belongs to the DM Large & Mid Cap segment. JPMorgan Healthcare Leaders ETF (JDOC) is part of the Global Blended Cap segment. PBPH's top 1 sector exposures are Healthcare. In contrast, JDOC's top sector exposures are Healthcare and Consumer Non-Cyclicals. PBPH is less expensive with a Total Expense Ratio (TER) of 0.13%, versus 0.65% for JDOC. PBPH is up 18.76% year-to-date (YTD) with +$1.00B in YTD flows. JDOC performs worse with 10.6% YTD performance, and -$34K in YTD flows. Run a side-by-side ETF comparison of PBPH and JDOC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

PBPH vs JDOC performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 10/28/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	PBPH JDOC	+4.21%+4.30%	+7.13%+2.92%	+18.76%+10.60%	n/a+16.91%	n/a+33.69%	n/an/a
Flows	PBPH JDOC	+$15M-	+$67M-	+$1.00B-$34K	--$34K	-+$7M	--

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	PBPH JDOC	+19.29%+15.74%	n/a+15.54%	n/a+14.83%	n/an/a
Max drawdown	PBPH JDOC	-6.98%-7.92%	n/a-9.66%	n/a-24.04%	n/an/a
Max drawdown duration	PBPH JDOC	55d64d	n/a154d	n/a704d	n/an/a

Trading data

Create an account to view trading data

Join for free

	PBPH	JDOC
Last sale 10/28/2026 at 1:30 PM	$30.01	$64.05
Previous close 10/28/2026	$29.97	$63.85
Consolidated volume 10/28/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of September 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

JDOC

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	PBPH	JDOC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 10/28/2026 at 1:30 PM

Live

Closed

	PBPH	JDOC
Last price	$30.01	$64.05
1D performance	+0.13%	+0.30%
AuM	$1.12 B	$9.60 M
E/R	0.13%	0.65%

Characteristics

	PBPH	JDOC
Management strategy	Passive	Active
Provider	Tidal	J.P. Morgan Asset Management
Benchmark	BITA Global Pharma and Biotech Select Index	-
N° of holdings	52	57
Asset class	-	-
Trailing 12m distribution yield	Join	Join
Inception date	November 24, 2025	November 1, 2023
ESG	No	No

More PBPH data on Trackinsight

More JDOC data on Trackinsight

Exposure

Countries

PBPH

USA

66.52%

Switzerland

10.05%

Other

23.44%

JDOC

USA

73.86%

Other

26.14%

Sectors

PBPH

Healthcare

99.55%

Other

0.45%

JDOC

Healthcare

96.33%

Other

3.67%

Diversification

PBPH

Total weight of top 15 holdings out of 15

74.6%

JDOC

Total weight of top 15 holdings out of 15

59.39%

Top 15 holdings

Data as of August 31, 2026

PBPH

Eli Lilly & Co.

14.74%

Johnson & Johnson

9.60%

AbbVie, Inc.

6.72%

Merck & Co., Inc.

5.42%

Amgen, Inc.

4.92%

Roche Holding AG

4.59%

Novartis AG

4.14%

Gilead Sciences, Inc.

3.99%

AstraZeneca PLC

3.52%

Pfizer Inc.

3.51%

Novo Nordisk A/S

3.23%

Vertex Pharmaceuticals, Inc.

3.02%

Bristol Myers Squibb Co.

2.99%

Sanofi

2.15%

GSK Plc

2.07%

JDOC

AbbVie, Inc.

7.91%

Eli Lilly & Co.

7.63%

Merck & Co., Inc.

5.32%

Johnson & Johnson

4.80%

Thermo Fisher Scientific, Inc.

4.15%

UnitedHealth Group, Inc.

3.64%

Bristol Myers Squibb Co.

3.52%

AstraZeneca PLC

3.48%

Abbott Laboratories

3.15%

Novo Nordisk A/S

2.95%

Roche Holding AG

2.80%

argenx SE

2.79%

Danaher Corp.

2.56%

GSK Plc

2.47%

CVS Health Corp.

2.24%

Frequently asked questions about PBPH and JDOC

How have the PBPH and JDOC ETFs performed in 2026?

As of October 28, 2026, PBPH is up 18.76% year-to-date (YTD), while JDOC has returned 10.6%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: PBPH or JDOC?

Year-to-date, the PBPH ETF saw +$1.00B in flows, compared to -$34K for JDOC.

Which ETF is bigger: PBPH or JDOC?

As of October 28, 2026, PBPH holds $1.12 B in assets under management (AUM), while JDOC manages $9.60 M.

What sectors do the PBPH and JDOC ETFs invest in?

PBPH leans toward sectors like Healthcare. Meanwhile, JDOC focuses on Healthcare.

What are the top holdings of the PBPH ETF and JDOC ETF?

PBPH top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. JDOC holds in its top three: AbbVie, Inc., Eli Lilly & Co. and Merck & Co., Inc..

PBPHvsJDOCETF Comparison

Portfolio Building Block World Pharma and Biotech Index ETF

JPMorgan Healthcare Leaders ETF

PBPH vs JDOC performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the PBPH and JDOC ETFs performed in 2026?

As of October 28, 2026, PBPH is up 18.76% year-to-date (YTD), while JDOC has returned 10.6%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: PBPH or JDOC?

Year-to-date, the PBPH ETF saw +$1.00B in flows, compared to -$34K for JDOC.

Which ETF is bigger: PBPH or JDOC?

As of October 28, 2026, PBPH holds $1.12 B in assets under management (AUM), while JDOC manages $9.60 M.

What sectors do the PBPH and JDOC ETFs invest in?

PBPH leans toward sectors like Healthcare. Meanwhile, JDOC focuses on Healthcare.

What are the top holdings of the PBPH ETF and JDOC ETF?

PBPH top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. JDOC holds in its top three: AbbVie, Inc., Eli Lilly & Co. and Merck & Co., Inc..

Which ETF is more diversified: PBPH or JDOC?

PBPH holds 53 securities with 74.6% of its assets in the top 15. JDOC has 58 securities and a top 15 weight of 59.39%.

ETFs’ Next Act: From Access to Selection